Antonino Guerrisi

Rome, 00144, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma.

Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 13, 2025

Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma.

Biopsy RNA-seq captures TROP-2-linked migration and clonal resistance to forecast aggressiveness in metastatic melanoma.

Journal: Journal of experimental & clinical cancer research : CR
Published: August 13, 2025

Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary Study.

Metastatic Melanoma Prognosis Prediction Using a TC Radiomic-Based Machine Learning Model: A Preliminary Study.

Journal: Cancers
Published: June 10, 2025

Thyroid Nodule Characterization: Which Thyroid Imaging Reporting and Data System (TIRADS) Is More Accurate? A Comparison Between Radiologists with Different Experiences and Artificial Intelligence Software.

Thyroid Nodule Characterization: Which Thyroid Imaging Reporting and Data System (TIRADS) Is More Accurate? A Comparison Between Radiologists with Different Experiences and Artificial Intelligence Software.

Journal: Diagnostics (Basel, Switzerland)
Published: May 13, 2025

Exploring Cutaneous Melanoma Patients' Experiences with Follow-Up Radiology: A Qualitative Study.

Exploring Cutaneous Melanoma Patients' Experiences with Follow-Up Radiology: A Qualitative Study.

Journal: Healthcare (Basel, Switzerland)
Published: February 13, 2025

A Machine Learning Model Based on Thyroid US Radiomics to Discriminate Between Benign and Malignant Nodules.

A Machine Learning Model Based on Thyroid US Radiomics to Discriminate Between Benign and Malignant Nodules.

Journal: Cancers
Published: October 07, 2024

Biobanks as an Indispensable Tool in the "Era" of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma.

Biobanks as an Indispensable Tool in the "Era" of Precision Medicine: Key Role in the Management of Complex Diseases, Such as Melanoma.

Journal: Journal of personalized medicine
Published: June 08, 2024

Cumulative Dose from Recurrent CT Scans: Exploring the DNA Damage Response in Human Non-Transformed Cells.

Cumulative Dose from Recurrent CT Scans: Exploring the DNA Damage Response in Human Non-Transformed Cells.

Journal: International journal of molecular sciences
Published: May 17, 2024

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.

Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.

Journal: International journal of molecular sciences
Published: January 13, 2023

Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation.

Factors to Consider for the Correct Use of γH2AX in the Evaluation of DNA Double-Strand Breaks Damage Caused by Ionizing Radiation.

Journal: Cancers
Published: November 22, 2022

Artificial Intelligence and Advanced Melanoma: Treatment Management Implications.

Artificial Intelligence and Advanced Melanoma: Treatment Management Implications.

Journal: Cells
Published: November 07, 2022

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach.

Exploring CT Texture Parameters as Predictive and Response Imaging Biomarkers of Survival in Patients With Metastatic Melanoma Treated With PD-1 Inhibitor Nivolumab: A Pilot Study Using a Delta-Radiomics Approach.

Journal: Frontiers in oncology
Published: May 03, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026